Oculis

Barcelona, Spain Founded: 2006 • Age: 20 yrs
Oculis is recognized as an ophthalmology institute in Spain.

About Oculis

Oculis is a company based in Barcelona (Spain) founded in 2006. It operates as a Professional Services. Oculis has raised $20.52 million across 1 funding round from investors including Bay City Capital, Novartis Venture Fund and Brunnur Ventures. Oculis offers products and services including Cataract Surgery, Refractive Surgery, and Pediatric Ophthalmology. Oculis operates in a competitive market with competitors including Clínica Baviera, Centro de Oftalmologia Barraquer, Optica Torres, Vistalser Oftalmologa Todos los derechos reservados and Deutsche Augen Klinik, among others.

  • Headquarter Barcelona, Spain
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website oculis.es
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $20.52M (USD)

    in 1 rounds

  • Latest Funding Round
    $20.52M (USD), Series B

    Jan 2018

  • Investors

Products & Services of Oculis

Oculis offers a comprehensive portfolio of products and services, including Cataract Surgery, Refractive Surgery, and Pediatric Ophthalmology.

Cataract Surgery
Ophthalmology

Surgical treatment for cataracts is provided to patients.

Refractive Surgery
Ophthalmology

Vision correction through refractive surgery is offered here.

Pediatric Ophthalmology
Ophthalmology

Eye care for children is delivered by specialists.

Funding Insights of Oculis

Oculis has successfully raised a total of $20.52M through 1 strategic funding round. The most recent funding activity was a Series B round of $20.52 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $20.52M
  • Total Rounds 1
  • Last Round Series B — $20.52M
  • First Round $20.52M

    (Jan 2018)

  • Investors Count 5

All 1 funding rounds of Oculis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2018$20.52MSeries B–Bay City Capital, Novartis Venture Fund
Valuation history

5 investors in total: 5 institutional.

Investors in Oculis

Oculis has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Bay City Capital, Novartis Venture Fund and Brunnur Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Stage-agnostic investments in US life-sciences sectors are managed.
–baycitycapital.comSan Francisco, United States
Investments are made in innovative life science companies globally.
–nvfund.comBasel, Switzerland
Venture capital investments are directed toward startups by the firm.
–brunnurventures.comReykjavik, Iceland
Silfurberg is engaged in venture capital investments internationally.
2002silfurberg.isReykjavík, Iceland
A global healthcare investment firm supporting therapeutic-focused companies.
2017pivotalbiovp.comSan Francisco, United States
Premium access

Investor details for Oculis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Oculis

2 dated milestones of Oculis across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Oculis is founded.
  2. Funding First funding round of $20.5M.

Competitors of Oculis

Oculis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clínica Baviera, Centro de Oftalmologia Barraquer, Optica Torres, Vistalser Oftalmologa Todos los derechos reservados and Deutsche Augen Klinik, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
clinicabaviera.com1992Madrid, Spain$50.82M–
Chain of eye care clinics
barraquer.com1941Barcelona, Spain––
Chain of eye care clinics
optica-torres.es1997La Algaba, Spain––
Provides eye examinations, glasses, lenses, and audiology solutions in Spain.
vista-laser.com2011Malaga, Spain––
Offers laser eye surgeries for vision correction and eye conditions.
deutsche-augen-klinik.de2018Santa Pola, Spain––
Provides eye examinations, surgeries, and treatments for vision conditions in Spain.
vallmedicvision.com2014Andorra, Spain––
Operates a chain of specialized eye care clinics.
oftalvist.es2011Alicante, Spain––
Provides ophthalmology treatments, surgeries, and consultations across clinics in Spain.
Premium access

Detailed competitors of Oculis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Oculis

The website of Oculis (oculis.es) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 5.5% vs previous month

Similar companies to Oculis

10 companies that operate in the same segment as Oculis (Hospitals & Clinical Care), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Maternity, childcare, and fertility services are delivered via hospital chains.
2007Bengaluru, Karnataka, IndiaUSD 204.87 MUSD 140.46 M4,459
Chain of oncology hospitals
1989Bengaluru, Karnataka, IndiaUSD 90.03 MUSD 270.51 M8,400
Chain of multi-super specialty healthcare hospitals
2004Gurugram, Haryana, IndiaUSD 104.7 MUSD 461.72 M12,240
Multispeciality secondary and tertiary care is provided by hospital chains.
1999Secunderabad, Telangana, IndiaUSD 62.46 MUSD 416.2 M6,490
Multispecialty hospitals are operated as a chain in India.
2001Delhi, Delhi, India–USD 889.96 M26,830
Multi-specialty hospitals and surgery centers are operated nationwide.
1968Nashville, Tennessee, United StatesUSD 97.27 MUSD 75.6 B316,000
Standalone veterinary clinics are operated for pet care services.
2017New York, New York, United StatesUSD 98.5 M––
Healthcare services, research, education, and community support are provided.
1942United States–––
Multispecialty hospitals are operated as a chain in India.
1991Bengaluru, Karnataka, IndiaUSD 645.32 MUSD 1.1 B–
Healthcare services are delivered through integrated hospital networks.
2002United States–––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Oculis

Oculis was founded in 2006 and raised its 1st funding round 12 years after it was founded.

Oculis is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

Oculis is a funded company, having raised a total of $20.52M across 1 funding round to date. The company's 1st funding round was a Series B of $20.52M, raised on Jan 2018.

Oculis is established as an ophthalmology institute based in Spain, specializing in a wide range of eye care services. Comprehensive treatments such as cataract surgery, refractive surgery, and pediatric ophthalmology are provided. Various eye conditions including glaucoma, retina issues, and strabismus are addressed. Emergency 24-hour ophthalmological care is also offered to patients. Diagnostic tests and visual therapy are included among the solutions delivered. The institute serves both individual patients and collaborates with medical centers and organizations in the healthcare sector.

Oculis offers Cataract Surgery, Refractive Surgery, and Pediatric Ophthalmology.

Oculis has 5 investors. Key investors include Bay City Capital, Novartis Venture Fund, Brunnur Ventures, Silfurberg, and Pivotal Life Sciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available